From the *Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France

†Hematology and Biosurgical Research Lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France

‡Carmat SA, Vélizy-Villacoublay, France

§Institut Curie, Paris, France

¶Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France

∥Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

#Université de Paris, PARCC, INSERM and Emergency department, AP-HP, Georges Pompidou European Hospital, Paris, France

**National Research Cardiac Surgery Center, Nur-Sultan (Astana), Kazakhstan

††Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France

‡‡Cardiac Surgery Department, AP-HP, Georges Pompidou European Hospital, Paris, France.

D.M.S., P.I., Y.P. and I.N. received consulting fees from CARMAT. C.P., C.L., A.C. and P.J. are employed by CARMAT-SAS. Other authors have no conflicts of interest to report.

This work was supported by grants of Carmat and PROMEX STIFTUNG FUR DIE FORSCHUNG Foundation.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML and PDF versions of this article on the journal’s Web site (www.asaiojournal.com).

Correspondence: David M. Smadja, PhD, Hematology department, European Georges Pompidou hospital, 20 rue Leblanc, 75015 Paris, France. E-mail: [email protected]; Twitter: @davidmsmadja.